mesothelioma

FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
BioSpace
Wed, 09/18/24 - 11:16 pm
Merck
Keytruda
mesothelioma
FDA
Oregon jury says Johnson & Johnson must pay $260M in mesothelioma talc case
Fierce Pharma
Tue, 06/4/24 - 11:27 pm
JNJ
legal
ovarian cancer
mesothelioma
Oregon
Breakthrough New Drug ‘Starves’ Cancer Caused By Asbestos
Forbes
Tue, 02/20/24 - 11:37 am
Polaris Pharmaceuticals
mesothelioma
asbestos
J&J ordered to pay mesothelioma patient $18.8M in talc case, pledges to appeal
Fierce Pharma
Wed, 07/19/23 - 11:46 am
JNJ
legal
mesothelioma
Sellas celebrates positive Phase I results in lung cancer
Clinical Trials Arena
Thu, 06/29/23 - 11:35 am
Sellas
clinical trials
immunotherapy
Opdivo
mesothelioma
lung cancer
Merck reports positive data from malignant pleural mesothelioma trial
Clinical Trials Arena
Mon, 03/13/23 - 10:01 am
Merck
Canadian Cancer Trials Group
clinical trials
Keytruda
mesothelioma
In PD-1 rivalry, Merck's Keytruda catches up with Opdivo in rare lung cancer type
Fierce Pharma
Fri, 03/10/23 - 11:20 am
Merck
Keytruda
Opdivo
Bristol Myers Squibb
pleural mseothelioma
mesothelioma
clinical trials
With another FDA nod, Eagle's Pemfexy gets up to speed with Lilly's Alimta
Fierce Pharma
Mon, 12/19/22 - 11:02 am
Eagle Pharmaceuticals
Pemfexy
Eli Lilly
mesothelioma
non-small cell lung cancer
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study
Fierce Biotech
Sun, 02/20/22 - 11:46 am
Atara Biotherapeutics
clinical trials
mesothelioma
CAR-T
patient deaths
SITC: Cellectis' off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice
Fierce Biotech
Fri, 11/12/21 - 11:41 am
Cellectis
CAR-T
cancer
pancreatic cancer
mesothelioma
SITC
Bristol Myers rolls out 3-year data mesothelioma data for Opdivo/Yervoy in first look at ESMO slate
Endpoints
Mon, 09/13/21 - 10:32 am
Bristol Myers Squibb
Opdivo
Yervoy
mesothelioma
Bristol Myers Squibb Drug Combination Wins FDA Approval for Mesothelioma
Motley Fool
Sun, 10/4/20 - 10:59 pm
Bristol-Myers Squibb
FDA
Opdivo
Yervoy
mesothelioma
Esmo 2020 – More encouraging signs for checkpoint bispecifics
EP Vantage
Tue, 09/22/20 - 10:56 am
ESMO
bispecifics
Macrogenics
Akeso
mesothelioma
AK104
MGD019
Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%
Fierce Pharma
Sat, 08/8/20 - 10:46 pm
WCLC
lung cancer
mesothelioma
Bristol-Myers Squibb
Opdivo
Yervoy
clinical trials
Targovax plans checkpoint combo trial after posting early data on oncolytic virus
Fierce Biotech
Wed, 01/22/20 - 10:58 am
Targovax
ONCOS-102
mesothelioma
clinical trials
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Pharmaforum
Fri, 08/30/19 - 10:48 am
Mylan
Eli Lilly
generics
Alimta
non-squamous non-small cell lung cancer
mesothelioma
Novocure Wins FDA Approval for First Mesothelioma Treatment in 15 Years
BioSpace
Fri, 05/24/19 - 01:00 pm
Novocure
NovoTTF-100L
mesothelioma
Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000
Fierce Pharma
Thu, 05/24/18 - 09:40 pm
JNJ
lawsuit
mesothelioma
Novocure touts top-line data from Ph2 mesothelioma trial
Drug Delivery Business News
Tue, 04/17/18 - 09:43 am
Novocure
clinical trials
mesothelioma
humanitarian device exemption
tumor treating fields
devices
Why ImmunoGen, Inc. Jumped Higher Today
Motley Fool
Tue, 07/25/17 - 12:01 am
Immunogen
anetumab ravtansine
Bayer
mesothelioma

Pages